Cachet Pharmaceutical Co., Ltd. (SHE:002462)
China
· Delayed Price · Currency is CNY 13.97
+0.15 (1.09%)
Apr 29, 2026, 3:04 PM CST
Cachet Pharmaceutical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 19,507 | 23,985 | 29,923 | 26,220 | 25,626 | Upgrade
|
| Other Revenue | 18.41 | 33.96 | 73.25 | - | - | Upgrade
|
| Revenue | 19,525 | 24,019 | 29,996 | 26,220 | 25,626 | Upgrade
|
| Revenue Growth (YoY) | -18.71% | -19.93% | 14.40% | 2.32% | 10.19% | Upgrade
|
| Cost of Revenue | 18,336 | 22,431 | 28,077 | 24,116 | 23,493 | Upgrade
|
| Gross Profit | 1,189 | 1,588 | 1,919 | 2,104 | 2,133 | Upgrade
|
| Selling, General & Admin | 533.28 | 882.78 | 1,052 | 1,153 | 1,088 | Upgrade
|
| Other Operating Expenses | 33.27 | 48.43 | 50.63 | 45.8 | 44.73 | Upgrade
|
| Operating Expenses | 813.62 | 1,027 | 1,187 | 1,273 | 1,159 | Upgrade
|
| Operating Income | 375.1 | 561.28 | 732.78 | 831 | 973.49 | Upgrade
|
| Interest Expense | -82.6 | -129.18 | -166.35 | -188.57 | -164.24 | Upgrade
|
| Interest & Investment Income | 15.6 | 19.48 | 31.12 | 22.43 | 18.66 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.21 | 0.57 | 0.18 | -0.66 | Upgrade
|
| Other Non Operating Income (Expenses) | -15.85 | -26.62 | -29.13 | -30.96 | -12.17 | Upgrade
|
| EBT Excluding Unusual Items | 292.25 | 424.74 | 568.99 | 634.08 | 815.08 | Upgrade
|
| Impairment of Goodwill | -48.94 | -80.41 | -40.05 | -20.21 | -13.71 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.03 | 0.04 | -3.5 | -2.63 | -0.52 | Upgrade
|
| Gain (Loss) on Sale of Assets | 4.31 | 201.43 | 0.85 | 1.67 | 0.74 | Upgrade
|
| Asset Writedown | -0.18 | -6.14 | -0.3 | -1.88 | -0.21 | Upgrade
|
| Other Unusual Items | 30.69 | 7.05 | 29.29 | 33.88 | 22.59 | Upgrade
|
| Pretax Income | 278.09 | 546.7 | 555.28 | 644.91 | 823.98 | Upgrade
|
| Income Tax Expense | 176.38 | 229.99 | 178.75 | 176.59 | 222.1 | Upgrade
|
| Earnings From Continuing Operations | 101.71 | 316.71 | 376.53 | 468.31 | 601.88 | Upgrade
|
| Minority Interest in Earnings | 9.67 | -158.57 | -126.47 | -171.38 | -248 | Upgrade
|
| Net Income | 111.38 | 158.14 | 250.06 | 296.94 | 353.88 | Upgrade
|
| Net Income to Common | 111.38 | 158.14 | 250.06 | 296.94 | 353.88 | Upgrade
|
| Net Income Growth | -29.57% | -36.76% | -15.79% | -16.09% | 11.43% | Upgrade
|
| Shares Outstanding (Basic) | 293 | 293 | 291 | 291 | 292 | Upgrade
|
| Shares Outstanding (Diluted) | 293 | 293 | 291 | 291 | 292 | Upgrade
|
| Shares Change (YoY) | 0.09% | 0.71% | -0.12% | -0.46% | 0.38% | Upgrade
|
| EPS (Basic) | 0.38 | 0.54 | 0.86 | 1.02 | 1.21 | Upgrade
|
| EPS (Diluted) | 0.38 | 0.54 | 0.86 | 1.02 | 1.21 | Upgrade
|
| EPS Growth | -29.63% | -37.21% | -15.69% | -15.70% | 11.01% | Upgrade
|
| Free Cash Flow | 1,369 | 164.93 | 1,396 | -351.98 | 666.17 | Upgrade
|
| Free Cash Flow Per Share | 4.67 | 0.56 | 4.80 | -1.21 | 2.28 | Upgrade
|
| Dividend Per Share | 0.115 | 0.170 | 0.260 | 0.310 | 0.370 | Upgrade
|
| Dividend Growth | -32.35% | -34.62% | -16.13% | -16.22% | 12.12% | Upgrade
|
| Gross Margin | 6.09% | 6.61% | 6.40% | 8.03% | 8.32% | Upgrade
|
| Operating Margin | 1.92% | 2.34% | 2.44% | 3.17% | 3.80% | Upgrade
|
| Profit Margin | 0.57% | 0.66% | 0.83% | 1.13% | 1.38% | Upgrade
|
| Free Cash Flow Margin | 7.01% | 0.69% | 4.65% | -1.34% | 2.60% | Upgrade
|
| EBITDA | 398.49 | 614.64 | 866.17 | 989.04 | 1,114 | Upgrade
|
| EBITDA Margin | 2.04% | 2.56% | 2.89% | 3.77% | 4.35% | Upgrade
|
| D&A For EBITDA | 23.39 | 53.36 | 133.39 | 158.03 | 140.26 | Upgrade
|
| EBIT | 375.1 | 561.28 | 732.78 | 831 | 973.49 | Upgrade
|
| EBIT Margin | 1.92% | 2.34% | 2.44% | 3.17% | 3.80% | Upgrade
|
| Effective Tax Rate | 63.42% | 42.07% | 32.19% | 27.38% | 26.96% | Upgrade
|
| Revenue as Reported | 19,525 | 24,019 | 29,996 | 26,220 | 25,626 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.